Home  /  About  /  Quality Medical Oversight Committee

Quality Medical Oversight Committee

A review board behind every clinical decision.

A standing, multi-specialty panel of board-certified physicians and senior nurses that checks whether it’s the right treatment — not just whether it can be billed.

Quality Medical Oversight Committee

A multi-specialty review board behind every clinical decision.

Specialty care is too high-stakes to leave to a single prescriber and a faxed prior authorization. The Quantify Quality Medical Oversight Committee — a standing panel of board-certified physicians across oncology, cardiology, endocrinology, infectious disease, and internal medicine, paired with senior clinical nurses — reviews complex cases for medical appropriateness, evidence-based protocol fit, and patient safety. We don't just check whether the treatment can be billed. We check whether it's the right treatment.

What the committee reviews

  • Complex oncology, autoimmune, rare-disease, and high-cost specialty cases
  • Treatment protocols proposed by the prescribing physician — against current evidence and patient-specific factors
  • Prior authorization decisions where the plan or PBM denial may be clinically wrong
  • Drug-drug interactions, contraindications, and physiologic risk profiles
  • Cases where a less invasive, equally effective therapy may be the better choice

Who sits on the committee

  • Alberto Montero, MD — Chair. Board-certified medical oncology.
  • Specialty physician advisors across cardiology, endocrinology, infectious disease, internal medicine, and pediatrics
  • Senior clinical RNs with infusion, oncology, and complex-care experience
  • Carl Black, PharmD — Chief Pharmacy Officer, voting member on dispensing and REMS questions
  • Liane Parker, RN, CPHM — Co-Founder & COO, ensures committee decisions reach the bedside

A recent committee review

A patient was scheduled to start systemic chemotherapy. Dr. Montero reviewed the case, pulled the pathology, staging, and recent imaging together, and identified that a less invasive, evidence-supported therapy was both safer for this patient's comorbidity profile and clinically superior given the actual tumor characteristics. The treatment plan was changed before the first cycle started. The patient avoided unnecessary toxicity, the plan avoided the cost of a wrong-protocol regimen, and the outcome was better — not because we moved faster, but because a physician actually looked at the chart.

This is the difference between specialty care that processes and specialty care that practices medicine.

Our specialty pharmacy arm

QuantifyRx is our URAC-accredited pharmacy inside the QSC Virtual Hospital Model — Specialty Pharmacy Services accreditation in progress.

REMS-Plus operations, EmberCube cold chain, named pharmacist per patient, dispensing wrapped in QSC's 24/7 Command Center and bedside nursing. For manufacturers, prescribers, and patients who want the specialty pharmacy side of what we do.